Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms
Author(s) -
Michael D. LaFleur,
Edinson Lucumi,
Andrew D. Napper,
Scott L. Diamond,
Kim Lewis
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq530
Subject(s) - potentiator , candida albicans , biofilm , antifungal , microbiology and biotechnology , nystatin , candida infections , candida auris , chemistry , biology , bacteria , pharmacology , genetics
Microbial adhesion and biofilms have important implications for human health and disease. Candida albicans is an opportunistic pathogen which forms drug-resistant biofilms that contribute to the recalcitrance of disease. We have developed a high-throughput screen for potentiators of clotrimazole, a common therapy for Candida infections, including vaginitis and thrush. The screen was performed against C. albicans biofilms grown in microtitre plates in order to target the most resilient forms of the pathogen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom